The early presence of positive tau‐PET in the inner regions of the temporal cortex in the absence of positive β‐amyloid markers does not merit the categorization of pre‐clinical AD according to the current definition of the NIA‐AA. This evidence concerns the gene MAPT and Alzheimer disease.